Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/9892
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKucia, A.-
dc.contributor.authorZeitz, C.-
dc.date.issued2002-
dc.identifier.citationHeart and Lung: the journal of acute and critical care, 2002; 31(2):113-121-
dc.identifier.issn0147-9563-
dc.identifier.issn1527-3288-
dc.identifier.urihttp://hdl.handle.net/2440/9892-
dc.description© 2002 Mosby, Inc. All rights reserved.-
dc.description.abstractBackground: Failed reperfusion after thrombolysis occurs in as many as 30% of patients with acute myocardial infarction (MI). Furthermore, some patients have incomplete tissue perfusion despite reperfusion of the infarct-related artery. Close assessment of the efficacy of thrombolytic administration in people with evolving acute MI is necessary, particularly with regard to myocardial perfusion status, because some patients may benefit from incremental pharmacologic or invasive reperfusion strategies. Purpose and Method: This article reviews a number of strategies to assess infarct-related artery patency and myocardial tissue perfusion. These include coronary angiography, continuous ST-segment monitoring, serial electrocardiography, obtaining serial serum biochemical markers of myocardial necrosis, monitoring for reperfusion arrhythmias, and assessment of changes in chest pain intensity. Conclusion: The early detection of failed reperfusion is critical if incremental strategies to enhance myocardial salvage are to be considered. Continuous ST-segment monitoring is a relatively inexpensive, reliable, and accurate tool for assessing real-time myocardial perfusion. (Heart Lung® 2002;31:113-21.)-
dc.description.statementofresponsibilityAngela Marie Kucia and Christopher James [sic] Zeitz-
dc.description.urihttp://www.elsevier.com/wps/find/journaldescription.cws_home/623089/description#description-
dc.language.isoen-
dc.publisherMosby Inc-
dc.source.urihttp://dx.doi.org/10.1067/mhl.2002.122649-
dc.subjectHumans-
dc.subjectMyocardial Infarction-
dc.subjectFibrinolytic Agents-
dc.subjectCoronary Angiography-
dc.subjectElectrocardiography-
dc.subjectTreatment Failure-
dc.subjectEmergency Treatment-
dc.subjectMyocardial Reperfusion-
dc.subjectSeverity of Illness Index-
dc.subjectRisk Assessment-
dc.subjectRisk Factors-
dc.subjectFollow-Up Studies-
dc.subjectVascular Patency-
dc.subjectFemale-
dc.subjectMale-
dc.subjectAngioplasty, Balloon, Coronary-
dc.titleFailed reperfusion after thrombolytic therapy: Recognition and management-
dc.typeJournal article-
dc.identifier.doi10.1067/mhl.2002.122649-
pubs.publication-statusPublished-
dc.identifier.orcidKucia, A. [0000-0002-7606-7717]-
dc.identifier.orcidZeitz, C. [0000-0001-8045-6873]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.